Literature DB >> 5663345

Contraception with an injectable progestin. A study of its use in postpartum women.

D R Mishell, M A el-Habashy, R G Good, D L Moyer.   

Abstract

Entities:  

Keywords:  Acceptors; Amenorrhea--etiology; Biology; Bleeding--etiology; Body Weight; Clinical Research; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Cytologic Effects; Depo-provera--side effects; Diseases; Endometrial Effects; Endometrium; Evaluation; Family Planning; Genitalia; Genitalia, Female; Injectables; Medroxyprogesterone Acetate--side effects; Menstruation Disorders; Ovulation; Physiology; Postpartum Women; Pregnancy; Research Methodology; Signs And Symptoms; Urogenital System; Uterine Effects; Uterus; Vaginal Abnormalities; Vaginal Desquamate Effects; Vaginitis

Mesh：

Substances：

Year:  1968        PMID： 5663345     DOI： 10.1016/0002-9378(68)90346-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  7 in total

Review 1.  Injectable contraception with depot medroxyprogesterone acetate. Current status.

Authors:  Andrew M Kaunitz; Allan Rosenfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

2.  Progestogen-induced luteinizing and follicle-stimulating hormone surge in postmenopausal women: a simulated ovulatory peak.

Authors:  W D Odell; R S Swerdloff
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

Review 3.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

Review 4.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

5.  Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.

Authors:  Karen H Lu; David S Loose; Melinda S Yates; Graciela M Nogueras-Gonzalez; Mark F Munsell; Lee-May Chen; Henry Lynch; Terri Cornelison; Stephanie Boyd-Rogers; Mary Rubin; Molly S Daniels; Peggy Conrad; Andrea Milbourne; David M Gershenson; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2013-05-02

6.  Endometrial histology of Depomedroxyprogesterone acetate users: a pilot study.

Authors:  Andrea Ries Thurman; David E Soper
Journal:  Infect Dis Obstet Gynecol       Date:  2006

7.  Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility.

Authors:  K K Smith-McCune; J F Hilton; U Shanmugasundaram; J W Critchfield; R M Greenblatt; D Seidman; S Averbach; L C Giudice; B L Shacklett
Journal:  Mucosal Immunol       Date:  2017-01-04       Impact factor: 7.313
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.